I

INDP

Indaptus Therapeutics Inc

1.600

-0.100-5.88%
After Hours: 1.590  -0.010  -0.63%19:35 04/02 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.650/1.700
TODAY RANGE1.570-1.655
VOL42.70K
MARKET CAP3.59M
52 WEEK RANGE1.520-19.91
AVG VOL (3M)58.14K
% TURNOVER1.90%
TURNOVER--
P/E (TTM)-0.0741
% RANGE5.00%
EPS(TTM)-21.5801
P/E(FORWARD)-0.2488
P/B1.100
BVPS1.454
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.21M
SHARES OUTSTANDING2.24M
NEXT EARNINGS05/12-05/18
FREE FLOAT1.38M
LOT SIZE1
EX-DATE06/27/2025
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

INDP

--

REGN

--

GRDX

--

B

BIONTECH

BNTX

+1.97%
91.18

聯合治療

UTHR

-0.96%
564.81

S

SIGA科技

SIGA

+1.35%
5.24

VRTX

--

MRNA

--

CRL

--

MEDP

--

TLPH

--

ICLR

--

CBPO

--

IQV

--

M

MOLECULAR PARTNERS AG

MOLN

-3.87%
3.850

PRAH

--

GILD

--

A

Arcturus醫療

ARCT

+2.29%
8.03

I

Incyte Corp

INCY

+1.73%
95.93

APVO

--

B

BioSpecifics生物

BSTC

+0.15%
88.53

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.